You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 3, March 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Signs and Symptoms of Tobacco Withdrawal

John R. Hughes, MD; Dorothy Hatsukami, PhD

Arch Gen Psychiatry. 1986;43(3):289-294.


Abstract

• To test the validity, magnitude, and clinical significance of the signs and symptoms of tobacco withdrawal defined by DSM-III, both observed and reported signs and symptoms were measured in 50 smokers during two days of ad lib smoking and then during the first four days of abstinence. Observer and subject ratings of the DSM-III symptoms of craving for tobacco, irritability, anxiety, difficulty concentrating, and restlessness increased after cessation. In addition, bradycardia, impatience, somatic complaints, insomnia, increased hunger, and increased eating occurred after cessation. The frequency and intensity of these symptoms varied across subjects; however, the average distress from tobacco withdrawal was similar to that observed in psychiatric outpatients. Subjects who had more withdrawal discomfort were more tolerant to the cardiovascular effects of nicotine. Subjects who had more withdrawal discomfort did not have a lower rate of smoking cessation.



Author Affiliations

From the Department of Psychiatry, University of Minnesota, Minneapolis.


Footnotes

Accepted for publication Sept 27, 1984.

Reprint requests to Department of Psychiatry, University of Vermont College of Medicine, Burlington, VT 05405 (Dr Hughes).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Why Won't Our Patients Stop Smoking?: The power of nicotine addiction
Mannino
Diabetes Care 2009;32:S426-S428.
FULL TEXT  

A randomized clinical trial of nicotine lozenge for smokeless tobacco use
Ebbert et al.
Nicotine Tob Res 2009;0:ntp154v1-ntp154.
ABSTRACT | FULL TEXT  

CO exposure, puff topography, and subjective effects in waterpipe tobacco smokers
Maziak et al.
Nicotine Tob Res 2009;11:806-811.
ABSTRACT | FULL TEXT  

Comparison of methods for measurement of smoking behavior: Mouthpiece-based computerized devices versus direct observation
Blank et al.
Nicotine Tob Res 2009;11:896-903.
ABSTRACT | FULL TEXT  

Nicotine Gum Treatment Before Smoking Cessation: A Randomized Trial
Etter et al.
Arch Intern Med 2009;169:1028-1034.
ABSTRACT | FULL TEXT  

Sustained-release bupropion for hospital-based smoking cessation: A randomized trial
Simon et al.
Nicotine Tob Res 2009;11:663-669.
ABSTRACT | FULL TEXT  

Nicotine enhances automatic temporal processing as measured by the mismatch negativity waveform
Martin et al.
Nicotine Tob Res 2009;11:698-706.
ABSTRACT | FULL TEXT  

A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction
Thornley et al.
Nicotine Tob Res 2009;11:715-721.
ABSTRACT | FULL TEXT  

Nicotinic Receptors in the Habenulo-Interpeduncular System Are Necessary for Nicotine Withdrawal in Mice
Salas et al.
J. Neurosci. 2009;29:3014-3018.
ABSTRACT | FULL TEXT  

Progressive Commercial Cigarette Yield Reduction: Biochemical Exposure and Behavioral Assessment
Benowitz et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:876-883.
ABSTRACT | FULL TEXT  

Anxiety sensitivity and anxiety and depressive symptoms in the prediction of early smoking lapse and relapse during smoking cessation treatment
Zvolensky et al.
Nicotine Tob Res 2009;11:323-331.
ABSTRACT | FULL TEXT  

Intention to quit moderates the effect of bupropion on smoking urge
Tidey and Rohsenow
Nicotine Tob Res 2009;11:308-312.
ABSTRACT | FULL TEXT  

Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation
Dent et al.
The Annals of Pharmacotherapy 2009;43:194-201.
ABSTRACT | FULL TEXT  

Rate of Nicotine Metabolism and Withdrawal Symptoms in Adolescent Light Smokers
Rubinstein et al.
Pediatrics 2008;122:e643-e647.
ABSTRACT | FULL TEXT  

Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi and Salas
Exp. Biol. Med. 2008;233:917-929.
ABSTRACT | FULL TEXT  

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
Aubin et al.
Thorax 2008;63:717-724.
ABSTRACT | FULL TEXT  

Body Acupuncture for Nicotine Withdrawal Symptoms: A Randomized Placebo-controlled Trial
Hyun et al.
Evid Based Complement Alternat Med 2008;0:nem179v2-nem179.
ABSTRACT | FULL TEXT  

Depressive Symptoms and Smoking Cessation After Hospitalization for Cardiovascular Disease
Thorndike et al.
Arch Intern Med 2008;168:186-191.
ABSTRACT | FULL TEXT  

Nicotine and Carcinogen Exposure with Smoking of Progressively Reduced Nicotine Content Cigarette
Benowitz et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:2479-2485.
ABSTRACT | FULL TEXT  

Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review
Rasmusson et al.
J Psychopharmacol 2006;20:693-707.
ABSTRACT  

Human Tobacco Smokers in Early Abstinence Have Higher Levels of beta2* Nicotinic Acetylcholine Receptors than Nonsmokers.
Staley et al.
J. Neurosci. 2006;26:8707-8714.
ABSTRACT | FULL TEXT  

Smoking Cessation With Varenicline, a Selective {alpha}4beta2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up.
Nides et al.
Arch Intern Med 2006;166:1561-1568.
ABSTRACT | FULL TEXT  

Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation.
Oncken et al.
Arch Intern Med 2006;166:1571-1577.
ABSTRACT | FULL TEXT  

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales et al.
JAMA 2006;296:47-55.
ABSTRACT | FULL TEXT  

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby et al.
JAMA 2006;296:56-63.
ABSTRACT | FULL TEXT  

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad et al.
JAMA 2006;296:64-71.
ABSTRACT | FULL TEXT  

The tobacco epidemic in Syria
Ward et al.
Tobacco Control 2006;15:i24-i29.
ABSTRACT | FULL TEXT  

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
O'Malley et al.
Arch Intern Med 2006;166:667-674.
ABSTRACT | FULL TEXT  

Guided Imagery for Smoking Cessation in Adults: A Randomized Pilot Trial
Tindle et al.
Complementary Health Practice Review 2006;11:166-175.
ABSTRACT  

Carcinogen Exposure during Short-term Switching from Regular to "Light" Cigarettes
Benowitz et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1376-1383.
ABSTRACT | FULL TEXT  

Determinants of smoking status: cross-sectional data on smoking initiation and cessation
van Loon et al.
Eur J Public Health 2005;15:256-261.
ABSTRACT | FULL TEXT  

Safety and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Addiction
Moolchan et al.
Pediatrics 2005;115:e407-e414.
ABSTRACT | FULL TEXT  

If smoking increases absences, does quitting reduce them?
Sindelar et al.
Tobacco Control 2005;14:99-105.
ABSTRACT | FULL TEXT  

Extended Nortriptyline and Psychological Treatment for Cigarette Smoking
Hall et al.
Am. J. Psychiatry 2004;161:2100-2107.
ABSTRACT | FULL TEXT  

Reversible Cigarette Smoke Extract-Induced DNA Damage in Human Lung Fibroblasts
Kim et al.
Am. J. Respir. Cell Mol. Bio. 2004;31:483-490.
ABSTRACT | FULL TEXT  

Influence of Nicotine Gum on Acute Cravings for Cigarettes
Davies et al.
J Psychopharmacol 2004;18:83-87.
ABSTRACT  

One year effectiveness of an individualised smoking cessation intervention at the workplace: a randomised controlled trial
Rodriguez-Artalejo et al.
Occup. Environ. Med. 2003;60:358-363.
ABSTRACT | FULL TEXT  

Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study
DiFranza et al.
Tobacco Control 2002;11:228-235.
ABSTRACT | FULL TEXT  

Sustained-Release Bupropion for Smoking Cessation in African Americans: A Randomized Controlled Trial
Ahluwalia et al.
JAMA 2002;288:468-474.
ABSTRACT | FULL TEXT  

Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation: A Randomized, Controlled Trial
Hays et al.
ANN INTERN MED 2001;135:423-433.
ABSTRACT | FULL TEXT  

Smoking Cessation in Adolescents: The Role of Nicotine Dependence, Stress, and Coping Methods
Siqueira et al.
Arch Pediatr Adolesc Med 2001;155:489-495.
ABSTRACT | FULL TEXT  

Phenotypic Characterization of an alpha 4 Neuronal Nicotinic Acetylcholine Receptor Subunit Knock-Out Mouse
Ross et al.
J. Neurosci. 2000;20:6431-6441.
ABSTRACT | FULL TEXT  

Initial symptoms of nicotine dependence in adolescents
DiFranza et al.
Tobacco Control 2000;9:313-319.
ABSTRACT | FULL TEXT  

The Novel 5-Hydroxytryptamine1A Antagonist LY426965: Effects on Nicotine Withdrawal and Interactions with Fluoxetine
Rasmussen et al.
J. Pharmacol. Exp. Ther. 2000;294:688-700.
ABSTRACT | FULL TEXT  

Depressive Symptoms and Cigarette Smoking Predict Development and Persistence of Sleep Problems in US Adolescents
Patten et al.
Pediatrics 2000;106:23e-23.
ABSTRACT | FULL TEXT  

Nicotine Patch Therapy in 101 Adolescent Smokers: Efficacy, Withdrawal Symptom Relief, and Carbon Monoxide and Plasma Cotinine Levels
Hurt et al.
Arch Pediatr Adolesc Med 2000;154:31-37.
ABSTRACT | FULL TEXT  

Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive
SHARFSTEIN
Tobacco Control 1999;8:210-213.
FULL TEXT  

A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation
Jorenby et al.
NEJM 1999;340:685-691.
ABSTRACT | FULL TEXT  

Obligatory Cessation of Smoking by Psychiatric Inpatients
Smith et al.
Psychiatr. Serv. 1999;50:91-94.
ABSTRACT | FULL TEXT  

Randomized Trial of Acupuncture for Nicotine Withdrawal Symptoms
White et al.
Arch Intern Med 1998;158:2251-2255.
ABSTRACT | FULL TEXT  

Reducing the addictiveness of cigarettes
Henningfield et al.
Tobacco Control 1998;7:281-293.
ABSTRACT | FULL TEXT  

A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt et al.
NEJM 1997;337:1195-1202.
ABSTRACT | FULL TEXT  

Smokeless Tobacco: an Addicting Drug
Henningfield et al.
ADR 1997;11:330-335.
ABSTRACT  

Varying Nicotine Patch Dose and Type of Smoking Cessation Counseling
Jorenby et al.
JAMA 1995;274:1347-1352.
ABSTRACT  

High-Dose Nicotine Patch Therapy: Percentage of Replacement and Smoking Cessation
Dale et al.
JAMA 1995;274:1353-1358.
ABSTRACT  

Smoking as a Risk Factor for Sleep-Disordered Breathing
Wetter et al.
Arch Intern Med 1994;154:2219-2224.
ABSTRACT  

Predicting Smoking Cessation: Who Will Quit With and Without the Nicotine Patch
Kenford et al.
JAMA 1994;271:589-594.
ABSTRACT  

Nicotine Patch Therapy for Smoking Cessation Combined With Physician Advice and Nurse Follow-up: One-Year Outcome and Percentage of Nicotine Replacement
Hurt et al.
JAMA 1994;271:595-600.
ABSTRACT  

Transdermal Nicotine: Clarifications, Side Effects, and Funding-Reply
Fiore and Jorenby
JAMA 1993;269:1940-1941.
ABSTRACT  

Tobacco Dependence and the Nicotine Patch: Clinical Guidelines for Effective Use
Fiore et al.
JAMA 1992;268:2687-2694.
ABSTRACT  

Effect of Transdermal Nicotine Delivery as an Adjunct to Low-Intervention Smoking Cessation Therapy: A Randomized, Placebo-Controlled, Double-blind Study
Daughton et al.
Arch Intern Med 1991;151:749-752.
ABSTRACT  

Symptoms of Tobacco Withdrawal: A Replication and Extension
Hughes et al.
Arch Gen Psychiatry 1991;48:52-59.
ABSTRACT  

Changes in Mood, Craving, and Sleep During Short-term Abstinence Reported by Male Cocaine Addicts: A Controlled, Residential Study
Weddington et al.
Arch Gen Psychiatry 1990;47:861-868.
ABSTRACT  

Legalization of Drugs: An Idea Whose Time Has Not Come
CLAYTON
American Behavioral Scientist 1989;32:316-332.
 

Effects of Transdermal Clonidine Treatment on Withdrawal Symptoms Associated With Smoking Cessation: A Randomized, Controlled Trial
Ornish et al.
Arch Intern Med 1988;148:2027-2031.
ABSTRACT  

Criteria of a Pharmacologic Withdrawal Syndrome
Goldstein
Arch Gen Psychiatry 1987;44:392-392.
ABSTRACT  

Physical Dependence on Nicotine in Gum: A Placebo Substitution Trial
Hughes et al.
JAMA 1986;255:3277-3279.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.